Table 4.
Univariate and Multivariate Cox Regression Analysis for OS in HCC Patients with Cirrhosis
| Univariate Cox regression |
Multivariate Cox regression |
|||||||
|---|---|---|---|---|---|---|---|---|
| Variables | P-value | HR | 95% CI | P-value | HR | 95% CI | ||
| Risk score (high/low) | 0.02 | 7.11 | 1.42 | 35.54 | 0.01 | 4.08 | 1.43 | 11.68 |
| Age (>60/≤60) | 0.02 | 7.34 | 1.3 | 41.57 | 0.03 | 2.86 | 1.09 | 7.56 |
| BMI | 0.21 | |||||||
| <25 | Reference | |||||||
| ≥25 | 0.48 | 0.07 | 3.13 | |||||
| Not reported | 25.56 | 0.37 | 1750.1 | |||||
| Race | 0.26 | |||||||
| Non-Asian | Reference | |||||||
| Asian | 0.25 | 0.05 | 1.31 | |||||
| AFP | 0.34 | |||||||
| ≤20ng/mL | Reference | |||||||
| >20ng/ml | 2.8 | 0.66 | 11.81 | |||||
| Not reported | 0.44 | 0.01 | 15.3 | |||||
| Gender(Male/Female) | 0.44 | 2.15 | 0.3 | 15.11 | ||||
| Hepatitis B or C | 0.1 | |||||||
| No | Reference | |||||||
| Yes | 0.17 | 0.03 | 0.87 | |||||
| Not reported | 0.28 | 0.01 | 10.28 | |||||
| Alcohol consumption | ||||||||
| No | 0.12 | Reference | ||||||
| Yes | 0.12 | 0.01 | 1.74 | |||||
| Histologic grade | 0.06 | |||||||
| G1-2 | Reference | |||||||
| G3-4 | 9.6 | 1.49 | 61.93 | |||||
| New tumor event | 0.79 | 0.69 | 0.05 | 10.32 | ||||
| Pathologic stage* | 0.7 | |||||||
| Stage I+II | Reference | |||||||
| Stage III+IV | 2.3 | 0.33 | 16.02 | |||||
| Cancer status | 0.37 | |||||||
| Tumor free | Reference | |||||||
| With tumor | 2.11 | 0.12 | 35.83 | |||||
| Not reported | 0.11 | 0 | 8.67 | |||||
| Family cancer history | 0.25 | |||||||
| No | Reference | |||||||
| Yes | 3.11 | 0.46 | 20.93 | |||||
| Not reported | 8.42 | 0.48 | 147.11 | |||||
| Residual tumor | 0.7 | |||||||
| R0 | 0.66 | 0.08 | 5.71 | |||||
| Vascular invasion | 0.21 | |||||||
| Negative | Reference | |||||||
| Positive | 3.61 | 0.87 | 14.91 | |||||
BMI, Body mass index; AFP, Alpha fetoprotein; HR, Hazard ratio; CI, Confidence interval; *TNM staging systems.